Inositol hexakisphosphate kinase 2 mediates growth suppressive and apoptotic effects of interferon-β in ovarian carcinoma cells

被引:132
作者
Morrison, BH
Bauer, JA
Kalvakolanu, DV
Lindner, DJ
机构
[1] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Dept Microbiol & Immunol, Baltimore, MD 21201 USA
[2] Cleveland Clin Fdn, Dept Canc Biol, Lerner Res Inst, Ctr Canc Drug Dev & Discovery,Taussig Canc Ctr, Cleveland, OH 44195 USA
关键词
D O I
10.1074/jbc.M101161200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interferons (IFNs) regulate the expression of genes that mediate their antiviral, antitumor, and immunomodulatory actions. We have previously shown that IFN-beta suppresses growth of human ovarian carcinoma xenografts in vivo and induces apoptosis of ovarian carcinoma cells in vitro. To investigate mechanisms of IFN-beta -induced apoptosis we employed an antisense technical knockout approach to identify gene products that mediate cell death and have isolated several regulators of interferon-induced death (RIDs). In this investigation, we have characterized one of the RIDs, RID-2. Sequence analysis revealed that RID-2 was identical to human inositol hexakisphosphate kinase 2 (IP6K2). IP6K2 is post-transcriptionally induced by IFN-beta in ovarian carcinoma cells. A mutant IP6K2 with substitutions in the putative inositol phosphate binding domain abrogates IFN-beta -induced apoptosis. These studies identify a novel function for IP6K2 in cell growth regulation and apoptosis.
引用
收藏
页码:24965 / 24970
页数:6
相关论文
共 37 条
[1]  
BARBER GN, 1995, MOL CELL BIOL, V15, P3138
[2]   Type 3 inositol 1,4,5-trisphosphate receptor modulates cell death [J].
Blackshaw, S ;
Sawa, A ;
Sharp, AH ;
Ross, CA ;
Snyder, SH ;
Khan, AA .
FASEB JOURNAL, 2000, 14 (10) :1375-1379
[3]  
DAMELL JE, 1997, SCIENCE, V277, P1630
[4]   A GENETIC TOOL USED TO IDENTIFY THIOREDOXIN AS A MEDIATOR OF A GROWTH INHIBITORY SIGNAL [J].
DEISS, LP ;
KIMCHI, A .
SCIENCE, 1991, 252 (5002) :117-120
[5]   Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays [J].
Der, SD ;
Zhou, AM ;
Williams, BRG ;
Silverman, RH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15623-15628
[6]   ANTIPROLIFERATIVE AND ANTI-VIRAL ACTIVITIES OF HUMAN-LEUKOCYTE INTERFERONS [J].
EVINGER, M ;
RUBINSTEIN, M ;
PESTKA, S .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1981, 210 (01) :319-329
[7]   RECOMBINANT INTERFERON ENHANCES MONOCLONAL-ANTIBODY - TARGETING OF CARCINOMA LESIONS INVIVO [J].
GREINER, JW ;
GUADAGNI, F ;
NOGUCHI, P ;
PESTKA, S ;
COLCHER, D ;
FISHER, PB ;
SCHLOM, J .
SCIENCE, 1987, 235 (4791) :895-898
[8]  
GREINER JW, 1984, CANCER RES, V44, P3208
[9]   INCREASED SURVIVAL IN MICE INOCULATED WITH TUMOR CELLS AND TREATED WITH INTERFERON PREPARATIONS [J].
GRESSER, I ;
BOURALI, C ;
LEVY, JP ;
FONTAINE.D ;
THOMAS, MT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1969, 63 (01) :51-&
[10]   ANTI-ONCOGENIC AND ONCOGENIC POTENTIALS OF INTERFERON REGULATORY FACTOR-I AND FACTOR-II [J].
HARADA, H ;
KITAGAWA, M ;
TANAKA, N ;
YAMAMOTO, H ;
HARADA, K ;
ISHIHARA, M ;
TANIGUCHI, T .
SCIENCE, 1993, 259 (5097) :971-974